PAUSHAK LIMITED
Latest filings
- Newspaper notice invites claims for shares transferred to IEPF · Compliance
- Newspaper notice on duplicate share certificates for 3,400 shares · Compliance
- Newspaper advertisement of Q2 FY26 unaudited financial results · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates as a single-segment specialty chemicals business, with FY26 revenue from operations of Rs 218.60 cr and total assets of Rs 659.94 cr. In Q1 FY27, revenue from operations reached Rs 83.55 cr, up 49.5% from Rs 55.88 cr in the same quarter a year earlier, while profit after tax rose to Rs 15.10 cr from Rs 12.03 cr. The cost structure is dominated by other operating expenses at 33.1% of revenue and materials at 26.2%, with employee costs at 18.2% and depreciation at 9.8%. Capital expenditure absorbs a notably high 40.3% of revenue, signalling an asset-heavy expansion mode relative to current turnover. The company sits within the Alembic group, with promoter/promoter-group entities including Alembic Pharmaceuticals Ltd and Shreno entities. An earlier share sub-division and 3-for-1 bonus issue were completed in October 2025, and a final dividend for FY26 was declared at the 53rd AGM, payable on or from 3 August 2026.
Scorecard
Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
PAUSHAKLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from PAUSHAK LIMITED's filed financials and exchange disclosures
What does PAUSHAK LIMITED do?
PAUSHAK LIMITED is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol PAUSHAKLTD.
Is PAUSHAK LIMITED profitable?
Yes. Over the trailing twelve months PAUSHAK LIMITED reported a net profit of ₹42 Cr on revenue of ₹246 Cr.
Does PAUSHAK LIMITED pay a dividend?
Yes. The dividend yield is 0.40% at the current price. It paid out 15% of its profit as dividend in FY26.
Is PAUSHAK LIMITED debt-free?
No. It reported borrowings of ₹77 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹77 Cr after cash. Debt stands at 0.16× equity. That is lower than 53% of its 99 Specialty Chemicals peers.
Is PAUSHAK LIMITED expensive compared with its peers?
On trailing P/E, PAUSHAK LIMITED ranks 25 of 99 in Specialty Chemicals — cheaper than 76% of them, against an industry median of 23.1×. This is a position, not a valuation judgement.
How much does the PAUSHAK LIMITED share price move in a day?
On a typical session PAUSHAK LIMITED moves 1.96% — that is the median absolute close-to-close move across its last 223 trading days. MarketPing measures each filing's price reaction against it.
Where can I track PAUSHAK LIMITED's announcements?
Every NSE and BSE filing by PAUSHAK LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.